Annual report [Section 13 and 15(d), not S-K Item 405]

Accounts Payable and Accrued Expenses (Details)

v3.26.1
Accounts Payable and Accrued Expenses (Details) - USD ($)
$ in Thousands
Dec. 31, 2025
Dec. 31, 2024
Accounts Payable and Accrued Expenses    
Accounts payable $ 3,510 $ 7,464
Accrued research and development 250 330
Accrued compensation 24 93
Other 1,627 1,599
Total accounts payable and accrued expenses 5,411 $ 9,486
Accrued consideration for the uBriGene Asset Purchase Agreement $ 1,300